|
|||||
|
|
A set of computational tools developed at Purdue University enables public safety agencies to monitor potentially catastrophic events in real time by analyzing text and images on social media. . . . → Read More: A.I. Helps Visualize Emergency Social Media Data 
A biotechnology company developing regenerative treatments for various disorders is licensing its lead therapy candidate for hearing loss to Astellas Pharma. . . . → Read More: Hearing Loss Cell Therapy Licensed in $625M Deal 
A new type of smart fabric can dramatically improve connectivity between wearable sensors and mobile devices compared to current wireless networks. . . . → Read More: Smart Fabrics Boost Wearable Sensor Connections 
A company designing treatments to restore the protective coating on nerve cells damaged by multiple sclerosis is collaborating with biotechnology enterprise Genentech. . . . → Read More: Genentech, Biotech Partner on Multiple Sclerosis 
A mobile and computer app that alerts older citizens about a class of drugs associated with Alzheimer’s disease will soon be tested in a clinical trial. . . . → Read More: Trial to Test App Alerting for Dementia-Linked Drugs 
A nationwide survey shows a majority of American adults, including half of those who smoke, did not see court-ordered anti-smoking TV or newspaper advertisements. . . . → Read More: Anti-Smoking Ads Not Reaching Most in U.S. 
Researchers expanded the ability of the genetic editing technique known as Crispr to alter the make-up of RNA, adding more ways to treat diseases. . . . → Read More: Crispr Enhanced for RNA Editing 
Labs in the U.S. and the Netherlands developed techniques to sustainably produce high-quality graphene with more capabilities, using a strain of bacteria. . . . → Read More: Bacteria Recruited to Produce Graphene 
A company founded earlier this year is receiving a small-business grant from NASA for a technology to remove small satellites and other debris from space. . . . → Read More: Start-Up Lands Grant to Clean-Up Space Debris 
A biotechnology enterprise developing personalized treatments for cancer and infectious diseases is raising $325 million in its second venture funding round. . . . → Read More: Immunotherapy Biotech Gains $325M in Venture Funds |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
